PicnicHealth | Biliary Tract Cancer

Biliary Tract Cancer: What to Know

For both significant classes of biliary tract cancer, significant signs or symptoms may not appear in early stages. Therefore, it can be quite difficult to detect. Frequently diagnosis occurs when the cancer has already reached its more advanced stages. Also, even though people of nearly any age can be diagnosed with biliary tract cancer. It’s often senior individuals around age 70 who are diagnosed with the disease.

Cholangiocarcinoma symptoms may include:

Other uncommon signs and symptoms are loss of appetite, fever, nausea, and vomiting.

Gallbladder cancer can be even harder to detect early; it doesn’t produce signs and symptoms until the cancer is already well advanced or if the tumor it’s caused has become unusually large.

Some critical signs and symptoms that gallbladder cancer does produce are:

Other less common potential symptoms include weight loss, loss of appetite, abdominal swelling, fever, itchy skin, dark urine, and pale stool. In other words, both gallbladder cancer and bile duct cancer can have similar symptoms but have different primary symptoms.

One important thing to remember about these cancers is that they are rare, and there is a chance that a different condition may cause some of the symptoms. It’s critical to consult a doctor to be able to make the correct diagnosis and prognosis for the patient.

So what causes biliary tract cancers? Cholangiocarcinoma is caused by DNA mutations in bile duct cells. DNA is the genetic material that functions as a set of instructions to give each cell in the body its purpose. If cells replicate out of control, they eventually form a tumor or a mass of cancerous cells. However, the specific conditions that lead to these genetic mutations remain unclear.

Gallbladder cancer forms when the DNA of healthy gallbladder cells also mutates. Instead of dying, the cells replicate out of control, forming a tumor that can grow well beyond the gallbladder and eventually spread toward other organs or parts of the body. The cancer typically begins around the glandular cells lining the inner surface of the gallbladder itself.

Cholangiocarcinoma itself is a rare occurrence in the Western world, with an incidence estimated at 0.5 to 2 people per 100,000. Roughly 8,000 people in the US are diagnosed with this disease every year. Rates are higher in Southeast Asia, as there may be parasitic infections that cause cancer to manifest. Asian countries may have up to 40 times higher rates of cholangiocarcinoma.

People of all ages can be diagnosed with the disease, though it mostly affects older people. The average age of the US population diagnosed with these types of cancer is 70 years old. For extrahepatic bile ducts, the age is 72 years old. The chances of surviving this type of cancer largely depend on where the disease is found and how advanced it is.

Gallbladder cancer, on the other hand, is somewhat more common. The American Cancer Society estimates nearly 12,000 cases are diagnosed each year, with slightly more women than men affected. A little over 4,000 people die from these cancers every year.

One of the most significant issues for gallbladder cancer is that it doesn’t present symptoms in the early stages, leading to diagnosis only after the disease has already advanced, making it far more challenging to manage and worsening the prognosis. Only one in five gallbladder cancers are discovered in their early stages when there is still ample time to stop it from spreading to other areas of the body. Chances for survival in gallbladder cancer largely depend on the extent of the disease when it is found.

Risk factors are things that affect a person’s chances of contracting a disease. Many bile duct cancer risk factors are chronic or long-standing conditions involving the bile duct, including:

Risk factors for gallbladder cancer include:

Biliary tract cancer can be particularly dangerous because both bile duct cancer and gallbladder cancer don’t show signs in early stages. Many people wouldn’t know that they had these cancers unless they went to a doctor to be diagnosed.

Most bile duct cancers and gallbladder cancers aren’t found until a medical specialist is consulted, and specific tests are performed. When diagnosing both these cancers to determine if a patient has them, the doctor may need to do the following tests:

Medications:

Doctors are still studying biliary tract cancer to determine the best method of treatment for them. By learning about gene and protein changes, they’re hoping to develop newer drugs to target those changes specifically. Chemotherapy is a common cancer treatment that uses drugs to kill cancerous cells. Targeted therapy is one way to treat these forms of cancer and work differently from standard chemotherapy drugs because it is directed at a narrower range of tissue.

Diet & Lifestyle:

While no specific diet has been proven to prevent or treat biliary tract cancer truly, there are diet and lifestyle changes that a person can make to limit the risk as much as possible. Maintaining a healthy weight and eating a balanced diet with a focus on plant foods can boost the body’s health and immune system. Staying active and getting plenty of physical exercises also helps.

Therapy and Procedures:

Chemotherapy– This therapy uses cancer-killing drugs administered via the mouth or IV. The drugs then spread throughout the body and the bloodstream, even in areas that cancer hasn’t reached yet, preventing it from spreading. While this form of therapy can be helpful for some people, it’s not yet clear how effective it is for biliary tract cancers.

Researchers’ major focus in biliary tract cancer is looking for new drugs and new treatments to help patients who suffer from these diseases. These include photodynamic therapies, immunotherapy, radiosensitizers, and other forms of targeted therapy. There is still no consistent cure for this type of cancer, so research seeks to find a cure as well as other treatments that may improve quality of life and extend life.

Clinical trials are a core part of the research process to ensure that new treatments are both effective and safe. In addition to clinical trials, researchers are increasingly making use of real-world evidence, which is information that is collected in the normal course of care for people with these cancers. Reviewing medical records and patient histories is particularly important for biliary tract cancers. Because these are cancers that don’t show visible signs and symptoms, comprehensive medical accounts are necessary to consider the symptoms and to make a correct diagnosis. Electronic health records that provide a very detailed look into the patient’s medical history and treatment are a treasure trove of information about the disease’s progression, signs, causes, and potential risks.